| Literature DB >> 32294939 |
Rosario Pignatello1, Pietro Matricardi2.
Abstract
Besides the feasibility for industrial scale-up, accelerating the translation from bench to bedside of new technological strategies for controlled delivery and targeting of drugs and other actives relevant for health management, such as medical devices and nutraceuticals, would benefit from an even earlier evaluation in pre-clinical models and clinical settings. At the same time, translational medicine also performs in the opposite direction, incorporating clinical needs and observations into scientific hypotheses and innovative technological proposals. With these aims, the sessions proposed for the 2019 CRS Italy Chapter Workshop will introduce the experience of Italian and worldwide researchers on how to foster the actual work in controlled release and drug delivery towards a reliable pre-clinical and clinical assessment.Entities:
Keywords: bioinformatics; clinical trials; controlled release; drug delivery; medical devices; nutraceuticals
Year: 2020 PMID: 32294939 PMCID: PMC7238002 DOI: 10.3390/pharmaceutics12040350
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321